Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
837

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular mechanism of crisaborole combined with erythromycin against methicillin-resistant <i>Staphylococcus aureus in vivo</i> and <i>in vitro</i>.

Frontiers in microbiology·2025
Same author

Screening of cytokines-cytokine receptor-associated genes in childhood asthma based on bioinformatics.

Integrative biology : quantitative biosciences from nano to macro·2025
Same author

Subcritical water extraction improves the ability of Auricularia cornea var. Li. Polysaccharides to stabilize hydrogels and emulsion gels.

International journal of biological macromolecules·2025
Same author

SALT OVERLY SENSITIVE2 and AMMONIUM TRANSPORTER1;1 contribute to plant salt tolerance by maintaining ammonium uptake.

The Plant cell·2025
Same author

Transdermal microneedle-assisted ultrasound-enhanced CRISPRa system to enable sono-gene therapy for obesity.

Nature communications·2025
Same author

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Signal transduction and targeted therapy·2025

Related Experiment Video

Updated: Jul 26, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

Association between Thyroid Cancer and CTLA-4 Gene Polymorphisms.

Liping Sun1, Tianfeng Niu2, Yi Zhang3

  • 1Endocrine Department, National Medicine Gezhouba Central Hospital, The Third Clinical Medical College of China Three Gorges University, Yichang, 443000, China. shachenjiu9881489@163.com.

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|June 17, 2023
PubMed
Summary

Cytotoxic T lymphocyte associate protein-4 (CTLA-4) gene polymorphisms are linked to thyroid cancer development. Specific CTLA-4 genotypes correlate with altered gene expression and clinical markers, suggesting CTLA-4 as a potential susceptibility factor.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Related Experiment Videos

Last Updated: Jul 26, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.5K

Area of Science:

  • Genetics
  • Oncology
  • Immunology

Background:

  • Thyroid cancer is a significant global health concern.
  • Cytotoxic T lymphocyte associate protein-4 (CTLA-4) plays a crucial role in immune regulation.
  • Understanding the genetic basis of thyroid cancer is vital for early detection and treatment.

Purpose of the Study:

  • To investigate the association between CTLA-4 gene polymorphisms and the risk of developing thyroid cancer.
  • To analyze the correlation between CTLA-4 genotypes and clinical indicators in thyroid cancer patients.

Main Methods:

  • Case-control study involving 200 thyroid cancer patients and 200 healthy controls.
  • Genotyping of CTLA-4 gene polymorphisms (rs3087243, rs606231417, rs1553657430) using polymerase chain reaction (PCR).
  • Quantification of CTLA-4 gene expression via RT-qPCR and statistical analysis of genotype-clinical index associations.

Main Results:

  • The G allele frequency at CTLA-4 rs3087243 was significantly higher in thyroid cancer patients (p=0.000).
  • Specific genotypes (GG at rs3087243, TT at rs606231417, CA at rs1553657430) were less frequent in controls (p<0.001).
  • CTLA-4 gene expression was elevated in patients with the CC genotype at rs1553657430 (p<0.05), and genotypes correlated with calcitonin and TSH levels.

Conclusions:

  • CTLA-4 gene polymorphisms are significantly associated with thyroid cancer progression.
  • Certain CTLA-4 genotypes may represent susceptibility factors for thyroid cancer.
  • Further research is warranted to elucidate the precise mechanisms linking CTLA-4 to thyroid cancer pathogenesis.